BR0102289A - Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica - Google Patents

Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica

Info

Publication number
BR0102289A
BR0102289A BR0102289-0A BR0102289A BR0102289A BR 0102289 A BR0102289 A BR 0102289A BR 0102289 A BR0102289 A BR 0102289A BR 0102289 A BR0102289 A BR 0102289A
Authority
BR
Brazil
Prior art keywords
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
diazepinoindoles
Prior art date
Application number
BR0102289-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Annette Doherty
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0102289A publication Critical patent/BR0102289A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0102289-0A 2000-06-09 2001-06-07 Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica BR0102289A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
BR0102289A true BR0102289A (pt) 2002-03-12

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102289-0A BR0102289A (pt) 2000-06-09 2001-06-07 Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica

Country Status (19)

Country Link
US (1) US6544983B2 (cs)
EP (1) EP1161949A1 (cs)
JP (1) JP2002138090A (cs)
KR (1) KR20010111457A (cs)
CN (1) CN1345725A (cs)
AR (1) AR030291A1 (cs)
AU (1) AU5181301A (cs)
BR (1) BR0102289A (cs)
CA (1) CA2347337A1 (cs)
CZ (1) CZ20011999A3 (cs)
EA (1) EA200100515A3 (cs)
HU (1) HUP0102388A3 (cs)
IL (1) IL143636A0 (cs)
MX (1) MXPA01005726A (cs)
NO (1) NO20012831L (cs)
NZ (1) NZ512222A (cs)
PL (1) PL347922A1 (cs)
SK (1) SK7832001A3 (cs)
ZA (1) ZA200104616B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
US20070167450A1 (en) * 2003-11-20 2007-07-19 Astellas Pharma Inc. Agent for treating chronic pelvic pain syndrome
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
AU2007274054B2 (en) 2006-07-10 2012-05-24 Paion Uk Limited Benzodiazepine salts
JP5240205B2 (ja) 2008-01-11 2013-07-17 アステラス製薬株式会社 精巣の疼痛又は不快感行動及び頻尿併発モデル動物
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
MA37581B1 (fr) * 2012-05-22 2016-07-29 Paion Uk Ltd Compositions comprenant des benzodiazépines à action rapide
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
EA200100515A3 (ru) 2002-06-27
CA2347337A1 (en) 2001-12-09
JP2002138090A (ja) 2002-05-14
NO20012831D0 (no) 2001-06-08
EP1161949A1 (en) 2001-12-12
IL143636A0 (en) 2002-04-21
EA200100515A2 (ru) 2001-12-24
KR20010111457A (ko) 2001-12-19
HUP0102388A2 (hu) 2002-04-29
PL347922A1 (en) 2001-12-17
AR030291A1 (es) 2003-08-20
NZ512222A (en) 2002-10-25
CZ20011999A3 (cs) 2002-04-17
NO20012831L (no) 2001-12-10
US20020010175A1 (en) 2002-01-24
CN1345725A (zh) 2002-04-24
HUP0102388A3 (en) 2004-11-29
AU5181301A (en) 2001-12-13
MXPA01005726A (es) 2003-08-20
US6544983B2 (en) 2003-04-08
SK7832001A3 (en) 2002-05-09
HU0102388D0 (en) 2001-08-28
ZA200104616B (en) 2002-10-30

Similar Documents

Publication Publication Date Title
BRPI0410170A (pt) preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR9806752A (pt) Ftalazinonas.
NL300877I2 (nl) obeticholzuur
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
ES2248356T3 (es) Compuestos para tratar la enfermedad de alzheimer.
NZ515392A (en) Respiratory syncytial virus replication inhibitors
EA200601591A1 (ru) Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0102289A (pt) Diazepinoindóis para o tratamento de doença pulmonar obstrutiva crÈnica
WO2002002520A3 (en) Compounds to treat alzheimer's disease
BR0113590A (pt) 7-oxo-piridopirimidinas
BR9911666A (pt) Combinação farmacêutica, uso da combinação, processo para tratamento de uma doença inflamatória em uma pessoa sofrendo de ou susceptìvel a tal doença, e, composição farmacêutica
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
BRPI0510084A (pt) benzoxazina para tratamento de doenças do trato respiratório
BR0110210A (pt) Compostos para o tratamento de fibromialgia e sìndrome de fadiga crÈnica
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BR0213037A (pt) Derivados de pirimidina
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
BR0213479A (pt) Utilização do irbesartan para a preparação de medicamentos úteis para a prevenção ou o tratamento da hipertensão pulmonar
BR0317947A (pt) Inibidores de quinurenina 3-hidroxilase para o tratamento de diabetes
BG106748A (en) Method and compositions for treating pulmonary diseases

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.